Table 2.
Crude and adjusted meta-regression analysis of the prevalence of AHD among ART-naïve patients
| Crude Coefficient | 95% CI | p-value | Adjusted Coefficient | 95% CI | p-value | |
|---|---|---|---|---|---|---|
| Publication year* | − 0.02 | -0.04 to -0.01 | 0.010 | -0.02 | -0.03 to 0.01 | 0.048 |
|
Data collection (Cross-sectional vs. Other) |
0.04 | -0.07 to 0.17 | 0.450 | -0.02 | -0.14 to 0.10 | 0.756 |
|
Setting (Inpatient vs. Outpatient) |
-0.23 | -0.44 to -0.03 | 0.026 | -0.18 | -0.40 to 0.04 | 0.109 |
| Methodological Quality Score* | -0.02 | -0.07 to 0.01 | 0.224 | -0.01 | -0.05 to 0.04 | 0.788 |
|
Assessment method (WHO Stage vs. CD4 count) |
0.16 | 0.01 to 0.32 | 0.048 | 0.10 | -0.05 to 0.26 | 0.202 |